Added to YB: 2022-04-26
Pitch date: 2022-04-26
DRRX [bullish]
DURECT Corporation
-54.52%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
DURECT Corporation, a biopharmaceutical company, develops medicines based on its epigenetic regulator program.
Market Cap
$58.4M
Pitch Price
$4.20
Price Target
N/A
Dividend
N/A
EV/EBITDA
-3.40
P/E
-3.91
EV/Sales
28.06
Sector
Pharmaceuticals
Category
N/A
Show full summary:
DURECT CORP DRRX
A summary for this pitch has not been created yet.
Read full article (0 min)